Capital Research Global Investors - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$593,301,598
+4.2%
6,623,148
-1.0%
0.16%
+6.5%
Q2 2023$569,547,350
+3.4%
6,689,539
+0.5%
0.15%
-2.5%
Q1 2023$550,597,151
+17.5%
6,653,742
+11.7%
0.16%
+10.6%
Q4 2022$468,444,434
+0.7%
5,956,064
-5.3%
0.14%
-7.2%
Q3 2022$465,373,000
+13.7%
6,286,276
+0.1%
0.15%
+19.5%
Q2 2022$409,424,000
+18.8%
6,281,436
+15.2%
0.13%
+50.6%
Q1 2022$344,676,000
+217.1%
5,452,006
+166.1%
0.08%
+254.2%
Q4 2021$108,686,000
+35.8%
2,049,133
+80.7%
0.02%
+26.3%
Q3 2021$80,031,000
-55.2%
1,133,748
-57.7%
0.02%
-54.8%
Q2 2021$178,551,000
-74.1%
2,679,336
-56.9%
0.04%
-75.1%
Q1 2021$690,204,000
+3.1%
6,217,498
+10.3%
0.17%
-2.9%
Q4 2020$669,481,000
+59.0%
5,637,735
+16.8%
0.17%
+38.1%
Q3 2020$421,026,000
+17.9%
4,825,515
+21.0%
0.13%
+11.5%
Q2 2020$357,166,000
+23.8%
3,988,003
+37.8%
0.11%0.0%
Q1 2020$288,396,000
-6.9%
2,893,800
+7.4%
0.11%
+21.5%
Q4 2019$309,633,000
-3.8%
2,694,800
+5.6%
0.09%
-12.3%
Q3 2019$321,783,000
+4.8%
2,551,0000.0%0.11%
+9.3%
Q2 2019$306,987,000
+148.5%
2,551,000
+80.6%
0.10%
+148.7%
Q1 2019$123,535,000
-12.6%
1,412,1500.0%0.04%
-20.4%
Q4 2018$141,286,000
-24.1%
1,412,150
-13.0%
0.05%
-9.3%
Q3 2018$186,078,000
+27.8%
1,624,0000.0%0.05%
+35.0%
Q2 2018$145,640,000
+62.6%
1,624,000
+32.7%
0.04%
+60.0%
Q1 2018$89,548,000
+336.2%
1,224,000
+246.3%
0.02%
+316.7%
Q4 2017$20,529,000353,4590.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders